EyePoint Pharmaceuticals
EYPT
#5229
Rank
ยฃ1.10 B
Marketcap
ยฃ13.38
Share price
0.45%
Change (1 day)
92.70%
Change (1 year)

EyePoint Pharmaceuticals (EYPT) - Cash on Hand

Cash on Hand as of September 2025 : ยฃ0.15 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company has ยฃ0.15 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

EyePoint Pharmaceuticals - Cash on Hand chart (from 2003 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ0.29 B13.75%
2023-12-31ยฃ0.25 B117.46%
2022-12-31ยฃ0.11 B-23.76%
2021-12-31ยฃ0.15 B375.7%
2020-12-31ยฃ32.94 M94.49%
2019-12-31ยฃ16.94 M
2018-06-30ยฃ29.35 M125.97%
2017-06-30ยฃ12.99 M-40.27%
2016-06-30ยฃ21.75 M19.58%
2015-06-30ยฃ18.19 M70.28%
2014-06-30ยฃ10.68 M58.11%
2013-06-30ยฃ6.75 M-27.25%
2012-06-30ยฃ9.28 M-38.23%
2011-06-30ยฃ15.03 M29.81%
2010-06-30ยฃ11.58 M176.63%
2009-06-30ยฃ4.18 M-46.61%
2008-06-30ยฃ7.84 M488.01%
2007-06-30ยฃ1.33 M-78.74%
2006-06-30ยฃ6.27 M13.35%
2005-06-30ยฃ5.53 M-53.76%
2004-06-30ยฃ11.96 M2388.69%
2003-06-30ยฃ0.48 M
2001-06-30ยฃ1.16 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NRC Health
NRC
ยฃ1.66 M-98.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
ยฃ0.09 M-99.94% Bahamas